19 Portal Vein Embolization
10.1055/b-0038-162890 19 Portal Vein Embolization David Li and David C. Madoff 19.1 Introduction The anticipated liver remaining after extensive hepatic resection, commonly described as the future liver remnant (FLR), is…
10.1055/b-0038-162890 19 Portal Vein Embolization David Li and David C. Madoff 19.1 Introduction The anticipated liver remaining after extensive hepatic resection, commonly described as the future liver remnant (FLR), is…
10.1055/b-0038-162892 21 Pancreatic Cancer Govindarajan Narayanan, Elizabeth Anne Hevert, and Shree Ramanan Venkat 21.1 Introduction Pancreatic cancer is an uncommon condition, accounting for approximately 3% of all cancer cases in…
10.1055/b-0038-162894 23 Yttrium-90 Radioembolization of Malignant Liver Tumors Christopher A. Molvar and Robert J. Lewandowski 23.1 Introduction The liver is a frequent site of metastatic disease, often of colorectal origin…
10.1055/b-0038-162889 18 Cholangiocarcinoma Aladin T. Mariano, R. Peter Lokken, and Charles E. Ray Jr. 18.1 Introduction Cholangiocarcinoma is an aggressive neoplasm of the biliary epithelium associated with significant morbidity and…
10.1055/b-0038-162891 20 Ablation of Malignant Liver Tumors Ronald S. Arellano 20.1 Introduction Over the past 15 years, image-guided tumor ablation has evolved to become a well-established therapeutic option for the…
10.1055/b-0038-162885 14 Imaging of Liver Tumors Christopher P. Coppa 14.1 Introduction This review will discuss the imaging features of commonly encountered malignant hepatic neoplasms. The computed tomography (CT) and magnetic…
10.1055/b-0038-162888 17 Management of Liver Metastases Terence P. F. Gade and Gregory J. Nadolski 17.1 Introduction The liver is a frequent site of metastatic disease. Although extra-abdominal malignancies can spread…
10.1055/b-0038-162887 16 Management of Locally Advanced Hepatocellular Carcinoma Olaguoke (Goke) Akinwande and Hyun S. Kim 16.1 Introduction Hepatocellular carcinoma (HCC) is an aggressive primary liver tumor that typically occurs in…
10.1055/b-0038-162883 12 Malignant Obstructive Jaundice Christopher R. Bailey and Kelvin Hong 12.1 Introduction Malignant tumors cause approximately 70 to 90% of all biliary obstructions. Several types of malignancies can lead…
10.1055/b-0038-162886 15 Hepatocellular Carcinoma: Staging and Clinical Management K. V. Narayanan Menon, Arvind R. Murali, Baljendra S. Kapoor, and Federico N. Aucejo 15.1 Introduction: Definition and Epidemiology Hepatocellular carcinoma (HCC)…